ChromaDex: Difference between revisions
Remove deleted template |
No edit summary |
||
| Line 8: | Line 8: | ||
| location = [[Irvine, California]], United States |
| location = [[Irvine, California]], United States |
||
| key_people = [[Frank Jaksch]]<br><small>([[Entrepreneur|Co-Founder]], CEO) |
| key_people = [[Frank Jaksch]]<br><small>([[Entrepreneur|Co-Founder]], CEO) |
||
| products = |
| products = Tru Niagen |
||
| homepage = ChromaDex.com |
| homepage = ChromaDex.com |
||
}} |
}} |
||
Revision as of 23:50, 21 May 2018
 | |
| Company type | Public |
|---|---|
| NASDAQ:CDXC | |
| Industry | Dietary supplements, food ingredients |
| Founded | 1999 |
| Headquarters | Irvine, California, United States |
Key people | Frank Jaksch (Co-Founder, CEO) |
| Products | Tru Niagen |
| Website | ChromaDex.com |
ChromaDex is a dietary supplement and food ingredient company based in Irvine, California founded in 1999 that is publicly traded on the NASDAQ.
ChromaDex has licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound trademarked as pTeroPure via the company's BluScience product line.[1] In 2011, Cornell University announced it granted ChromaDex exclusive worldwide rights to a novel manufacturing process for nicotinamide riboside which it markets and sells as an ingredient under the brand name Niagen.[2]
ChromaDex also offers contract research services that help customers source raw materials, identify new compounds and develop processes for large scale manufacturing.[3]
As of 2012 American billionaire and pharmaceutical entrepreneur Phillip Frost owned approximately 19% of ChromaDex.[4]
ChromaDex sells ingredients to third parties that market them under their own labels. Elysium Health bought the ingredients in its "Basis" product from ChromaDex.[5] ChromaDex and Elysium had an agreement under which Elysium didn't have to acknowledge ChromaDex as the source of the ingredients, but then after Elysium recruited the head of manufacturing from ChromaDex and stopped paying ChromaDex, ChromaDex sued Elysium and the information became public.[6]
See also
References
- ^ Neeb, Matthew (2011-06-20). "Ole Miss grants exclusive patent rights to ChromaDex Corp". The Daily Mississippian. Retrieved 2012-05-25.
- ^ "Got nicotinamide riboside?". Life Extension. 2007-05-04. Retrieved 2012-05-29.
- ^ "OTC Markets Stock Profile CDXC". OTC Markets. Retrieved 2016-03-21.
- ^ "ChromaDex Corp. Names Consumer Products Veteran Jeffrey Himmel CEO". 2012-01-23. Retrieved 2012-05-29.
- ^ Zhang, Sarah (July 6, 2016). "The Weird Business Behind a Trendy "Anti-Aging" Pill". Wired.
- ^ Buhr, Sarah (January 16, 2017). "A new lawsuit alleges anti-aging startup Elysium Health hasn't paid its sole supplier". TechCrunch.